DIANNE KYLE: Open Payments
NPI 1770934655 · DELTONA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 68 payments from 12 companies in 2025. Trend: 2023 $1,638 · 2024 $3,300 · 2025 $2,525
Food & beverage: $2,514Education: $11
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $607 |
| Novo Nordisk Inc | 15 | $503 |
| ABBVIE INC. | 17 | $496 |
| Amgen Inc. | 10 | $400 |
| Corcept Therapeutics | 2 | $137 |
| Exeltis, USA Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $114 |
| Lilly USA, LLC | 2 | $43 |
| PFIZER INC. | 2 | $41 |
| Exact Sciences Corporation | 1 | $24 |
Products named: AIRSUPRA, Ozempic, QULIPTA, VRAYLAR, Wegovy, Korlym, KRYSTEXXA, Veozah.
Industry payments across FL — which companies pay providers there.
